Clinical Trials Browser

OTHER × Prostatic Neoplasms, Castration-Resistant × abiraterone × Clear all

NCT03173859 2020-11-18

AERA

Phase 2 Withdrawn

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT02254785 2017-12-06

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms, Castration-Resistant